Peter Cicala
Director/Board Member at ETERNA THERAPEUTICS INC.
Profile
Peter Cicala is the founder of Boundless Bio, Inc. (founded in 2019).
He is currently working as an Independent Director at Eterna Therapeutics, Inc. since 2024.
Previously, he held the position of Chief Intellectual Property Counsel at Intercept Pharmaceuticals, Inc. from 2020 to 2021 and Chief Patent Counsel at Celgene Corp.
from 2014 to 2019.
Mr. Cicala completed his undergraduate degree at Fairleigh Dickinson University and his graduate degree at Seton Hall University School of Law.
Peter Cicala active positions
| Companies | Position | Start |
|---|---|---|
| ETERNA THERAPEUTICS INC. | Director/Board Member | 12/02/2024 |
Former positions of Peter Cicala
| Companies | Position | End |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2021 |
| CELGENE | Corporate Officer/Principal | 01/11/2019 |
| BOUNDLESS BIO, INC. | Founder | - |
Training of Peter Cicala
| Seton Hall University School of Law | Graduate Degree |
| Fairleigh Dickinson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Peter Cicala
